Significantly Extending Healthy Life Expectancy

Our company endorses April Dream, an initiative to make April 1st a day for sharing dreams. This press release represents the dream of "Nichimo Biotics Co., Ltd."
Nichimo Biotics Co., Ltd. (Headquarters: Minato-ku, Tokyo; Representative Director: Akihide Kitatani; a wholly-owned subsidiary of Nichimo Co., Ltd.) specializes in the research and development of koji-fermented soybeans and isoflavones as a health food manufacturer. We supply koji-fermented soybean germ extract, product name 'AglyMax®', and koji-fermented soybean culture, product name 'ImmuBalance®', to the market, both produced using our unique koji fermentation technology for which we obtained manufacturing patents in Japan, the U.S., and Europe (Note: The manufacturing patents have expired). Furthermore, we have accumulated extensive evidence through long-term joint research with many renowned universities both domestically and internationally.
Recently, fermentation has become a boom. Fermentation is expected to improve "absorbability," "taste," and "nutritional value." However, there is still much unknown about fermentation, which means it holds many untapped fascinations.
We conduct research and development with "fermentation" of "soybeans" by "koji mold" as our core technology, emphasizing an evidence-based approach. We often obtain significant data through fermentation that would not have been possible without it. Through health food ingredients created with this manufacturing technology of "fermenting" "soybeans" with "koji mold," we aim to continue striving for the extension of healthy life expectancy and the improvement of life satisfaction.